Clinical Trial: COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: a Multicenter, Randomized, Controlled Clinical Trial

U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06796764) titled 'COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: a Multicenter, Randomized, Controlled Clinical Trial' on Jan. 22.

Brief Summary: Hypoxia represents the prevailing adverse occurrence during the sedation of patients undergoing gastrointestinal endoscopy with propofol. This is particularly true for obese patients, who have a higher incidence of hypoxia. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bite block , oxygenation support, and oropharyngeal airway management. This dev...